Back to Authors

Morse, Mark A.

0009-0002-0658-5348

Mayo Clinic

University of Colorado Cancer Center

Citations 2

A phase 2 trial of high-dose Allovectin-7 in patients with advanced metastatic melanoma
Richards, Jon, Bedikian, A. Y., González, René , Whitman, Eric D. , Morse, Mark A. , Amatruda, Thomas, Galanis, E., Atkins, Michael B. , Lutzky, Jose

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 7509-7509

10.1200/jco.2004.22.90140.7509 Get It

High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial
Richards, Jon, Bedikian, A. Y., González, René , Whitman, Eric D. , Morse, Mark A. , Amatruda, Thomas, Galanis, E., Thompson, Joyce, Atkins, Michael B. , Lutzky, Jose

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7543-7543

10.1200/jco.2005.23.16_suppl.7543 Get It